Sermorelin cost and pricing: what it actually runs in 2026

Last updated 2026-07-24

How much does sermorelin cost per month?

Most people paying for sermorelin through a legitimate telehealth or in-person prescriber route land somewhere between $150 and $500 a month. Where you fall in that range depends mostly on dose (a typical starting protocol is a small nightly subcutaneous injection), whether the price bundles in provider visits and lab work, and which compounding pharmacy fills the prescription. That range isn't a marketing number, it's just what tends to show up once you strip out the outliers. Clinics that include monthly telehealth check-ins, bloodwork (IGF-1 levels are the usual marker tracked), and pharmacy shipping in a flat fee sit at the higher end. Cash-pay setups where you're paying the pharmacy directly and seeing a prescriber only for the initial script tend to sit lower. The one thing that should raise an eyebrow: sermorelin priced like a $60 research chemical. There is no FDA-approved, commercially manufactured sermorelin product on the market anymore (more on that below), so anything filling a legal prescription is going through the extra cost of pharmacy compounding, sterility testing, and licensed handling. That costs money. When the price doesn't reflect any of that overhead, ask why.

Why is there no brand-name sermorelin to compare prices against?

Sermorelin was sold in the US under the brand name Geref, an FDA-approved growth-hormone-releasing hormone product. It was discontinued by the manufacturer, not pulled for a safety problem. That's a distinction worth being precise about: discontinuation is usually a business decision (small market, more profitable alternatives, manufacturing cost), while a withdrawal implies the FDA or the company found a safety or efficacy issue. You can check the FDA's own drug database for the current approval status of any product, including discontinued ones, through Drugs@FDA ^[1]. Because there's no branded, mass-manufactured version left, every legal sermorelin option today comes from a compounding pharmacy operating under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, using sermorelin acetate as a bulk drug substance. The FDA maintains lists of bulk substances that compounders are allowed to use under these sections ^[2][3], and sermorelin's regulatory history as a formerly approved drug is part of why it's treated differently than never-approved research peptides. This matters for pricing because compounding isn't free. A 503A pharmacy (patient-specific prescriptions) or 503B outsourcing facility (larger batch production under stricter oversight) both have to follow sterility and quality rules under 21 U.S.C. 353a ^[4]. That regulatory overhead is baked into any legitimate price you'll see quoted.

What actually drives the price up or down?

A handful of variables explain almost all the price spread you'll see between clinics and pharmacies. Dose and vial size. Sermorelin is typically dosed in the range of a few hundred micrograms per night, and pharmacies sell vials sized to a month's supply at a given dose. Higher doses mean more drug per vial, which means a higher ingredient cost passed to you. Whether visits are bundled. Telehealth models that include a prescriber consult, dose adjustments, and periodic labs in a flat monthly fee will look more expensive than a bare pharmacy price, but you're paying for actual medical oversight, more than the vial. Pharmacy compounding standard. 503B outsourcing facilities operate under more stringent manufacturing controls than typical 503A community pharmacies and that can show up in price. It can also show up in your comfort level about what's actually in the vial. Supplements to delivery. Some protocols add other secretagogues or peptides to the regimen. If you're reading about stacking tesamorelin and sermorelin, know that adding a second peptide adds a second cost, and the combined safety and dosing picture is less studied than sermorelin alone. Insurance. Essentially none of this is covered by insurance for adult use. Sermorelin for adult-onset growth hormone concerns is considered an off-label, cash-pay therapy in almost every case.

Sermorelin vs HGH: which actually costs less, and which is the better buy?

This is the question most people are really asking when they start pricing sermorelin. The honest answer: sermorelin is cheaper, but it's not simply a discount version of HGH, and it's not always the better choice. Sermorelin is a growth-hormone-releasing hormone (GHRH) analog. It stimulates your own pituitary gland to release growth hormone in a pulsatile pattern, the way your body naturally does. HGH (somatropin) is the actual hormone itself, injected directly. Because sermorelin works upstream, it depends on your pituitary still being capable of responding, which is part of why a 2006 review describes it as a strategy that preserves the body's natural feedback loops rather than overriding them ^[5]. On price, sermorelin is almost always cheaper per month than pharmacy-grade HGH, largely because it's a smaller, simpler peptide to manufacture and dose. HGH prescriptions for adult growth hormone deficiency, which require a documented diagnosis, often run into four figures monthly depending on dose and brand. On effect size, this is where sermorelin is honestly the weaker choice for some goals. A 2020 review in Translational Andrology and Urology on growth hormone secretagogues in hypogonadal men body composition management notes these agents work through the endogenous GH-IGF-1 axis rather than delivering hormone directly ^[6], and a 2017 study found growth hormone secretagogue treatment in hypogonadal men raised serum IGF-1 levels ^[7], but the magnitude of change is generally more modest than what direct HGH replacement produces, and the two aren't interchangeable in a diagnosed GH deficiency situation. If your prescriber has documented true adult growth hormone deficiency, HGH is the FDA-approved, evidence-backed replacement therapy. Sermorelin is a lower-intensity, lower-cost approach more often used off-label for people who don't meet strict GHD criteria but want to support their own GH output. If you want the fuller before-and-after picture on what people actually report, sermorelin peptide before and after covers that separately. For the mechanism comparison against a specific oral secretagogue, see MK-677 vs sermorelin.

Cost comparison table: sermorelin vs HGH vs other GH secretagogues

Why do some sellers offer sermorelin so cheap?

When you see sermorelin priced far under the $150 to $500 range with no prescription required, you're almost never looking at a pharmacy product. You're looking at a research-chemical vial sold for "laboratory use only," often through the same grey market that supplies bodybuilding and performance-enhancement forums. This market is real and well documented. A 2016 investigation into falsified biopharmaceutical injectables in Europe found a meaningful share of product seized in enforcement operations was substandard or falsified ^[8]. A 2026 review in Frontiers in Endocrinology on performance-enhancing peptides describes a widening gap between the clinical evidence base for GH-IGF-1 axis peptides and the reality of patient self-administration outside medical supervision ^[9]. Separately, a 2026 critical review in The Journal of Sports Medicine and Physical Fitness covers the broader rise of peptide and peptide-analog drug use in recreational and professional sport and bodybuilding ^[10]. None of this means every cheap vial is contaminated. It means you have no pharmacy, no sterility testing, and no prescriber checking your labs standing between you and whatever is actually in the bottle. That's the real price difference: more than dollars, and who is accountable for what you're injecting. Anti-doping labs have had to build increasingly sensitive methods just to detect GHRH analogs like sermorelin in urine and blood, using techniques like immunoaffinity purification with high-resolution mass spectrometry ^[11][12] and nanoLC-HRMS/MS methods sensitive to low picogram-per-milliliter concentrations ^[13]. Researchers have also studied the stability and degradation of GHRP and GHRH-related peptides using enzymatic and serum-based methods ^[14]. That level of analytical effort exists precisely because unregulated GHRH use is common enough to need policing, which tells you something about how large the grey market really is.

What's included in a legitimate sermorelin prescription price?

A price quote from a licensed telehealth provider or in-person clinic should be able to tell you exactly what you're paying for. At minimum, expect these line items, bundled or itemized: The medical visit. A prescriber has to evaluate you, which for sermorelin usually means reviewing symptoms, history, and sometimes baseline labs, before writing a script. This isn't optional overhead, it's the legal basis for the prescription existing at all. Lab work. IGF-1 is the standard marker used to track response, since sermorelin's downstream effect runs through the GH-IGF-1 axis. Not every clinic includes this in the base price. The compounded medication itself. This is the vial, compounded by a licensed 503A or 503B pharmacy, dispensed to you or shipped directly. Ask which pharmacy is filling the script. A legitimate provider will name it without hesitation. Supplies. Syringes, alcohol swabs, and sharps disposal are sometimes included, sometimes billed separately. Follow-up. Dose adjustments after the first month are common and should be part of ongoing care, not a reason for a surprise fee. If you're trying to find a provider who can walk you through all of this locally or via telehealth, sermorelin peptide therapy near me breaks down what to look for in a legitimate clinic.

Injection vs oral: does the delivery method change the price?

Yes, meaningfully. Injectable sermorelin is the form with an actual regulatory and research history, going back to its approved Geref formulation and continuing through modern compounded versions. Oral GH secretagogue products marketed as sermorelin alternatives are a different category entirely, usually unapproved, and not standardized the way an injectable compounded product is. Price isn't really the deciding factor here, legitimacy is. An oral product that skips injection convenience but also skips pharmacy oversight isn't a discount, it's a different risk profile. For the fuller comparison of what changes between injectable and oral routes, see sermorelin peptide injection vs oral.

Is sermorelin worth the cost compared to just waiting or doing nothing?

This is a fair question and one worth answering honestly rather than with marketing enthusiasm. Sermorelin's evidence base is real but narrow. Its strongest historical use case is diagnostic and pediatric: a 1999 review describes its role in diagnosing and treating idiopathic growth hormone deficiency in children ^[15], and a 2006 clinical review frames it as a management option for adult-onset growth hormone insufficiency specifically ^[5]. Outside those contexts, evidence for broader adult use, body composition changes in aging or hypogonadal men, gets thinner. The 2020 Translational Andrology and Urology review is careful to frame growth hormone secretagogues as one tool within a modern approach to body composition management in hypogonadal males ^[6], not a guaranteed outcome. A small 2017 study found IGF-1 increases with secretagogue treatment in hypogonadal men ^[7], but that's a biomarker change, not a validated measure of how someone looks or feels. There's also emerging interest outside metabolic use: a 2021 paper in Annals of Translational Medicine discusses sermorelin as a potentially effective drug for patients with recurrent glioma ^[16], an early and specific research direction that has nothing to do with body composition or anti-aging use and shouldn't be read as supporting those claims. So is it worth the $150 to $500 a month? That depends entirely on what you're using it for and whether a prescriber has a legitimate clinical reason to put you on it, backed by labs before and during treatment. It's not worth it as a cheap HGH substitute bought without medical oversight. It may be reasonable as part of a monitored plan for a documented issue, discussed with a prescriber who can order the right labs and adjust dose.

What are the real safety and monitoring costs people forget to budget for?

The sticker price on a vial isn't the whole cost of a sermorelin course. Ongoing monitoring is where a lot of people underspend, and where problems get missed. GH-axis therapies, including secretagogues, aren't risk-free just because they act "more naturally" than direct HGH. A 2026 case report in Frontiers in Surgery describes anterior cervical osteophyte-related dysphagia in a long-term growth hormone user ^[17], a reminder that GH axis manipulation over long periods carries physical risks that need clinical eyes on them, more than a repeat prescription. That case involved growth hormone use broadly, not sermorelin specifically, but it's a useful flag for why periodic evaluation matters for anyone on a long-term GH-axis protocol. Budget for at least one follow-up lab panel in your first three months, and don't choose a provider who skips this to keep the price low. Cheap without monitoring isn't a deal, it's just cheap.

How does sermorelin pricing compare across pharmacy types (503A vs 503B)?

Section 503A of the FD&C Act covers pharmacies compounding patient-specific prescriptions, typically smaller-batch and often what you'll encounter through a local compounding pharmacy ^[3][4]. Section 503B covers outsourcing facilities that can compound in larger batches under current good manufacturing practice-like oversight, without a patient-specific prescription required for each batch ^[2]. 503B facilities generally have higher compliance overhead, which can mean slightly higher prices, but also more consistent quality control documentation. Neither is inherently the wrong choice; the FDA's own bulk drug substance lists for both sections determine what's legally allowed to go into your vial in the first place ^[18][19]. If a provider can't tell you which type of facility is compounding their sermorelin, that's worth asking about directly before you pay.

Bottom line: what should you actually expect to pay?

Budget $150 to $500 a month for legitimately prescribed, pharmacy-compounded sermorelin, with the higher end reflecting bundled telehealth visits and lab monitoring. Anything dramatically below that, especially with no prescription requirement, is a research-chemical product, not a medical one, whatever the seller calls it. If you're looking for a starting point on the legitimate provider-reviewed route, the main sermorelin overview covers what the therapy is and how it's typically dosed before you get to a cost conversation. Providers working through Sermorelin Co connect patients to prescribers who work with licensed compounding pharmacies rather than unregulated suppliers, which is the difference that actually matters once you've priced out your options.

Frequently asked questions

How much does sermorelin cost without insurance?

Expect roughly $150 to $500 or more per month out of pocket. Insurance essentially never covers sermorelin for adult off-label use, since it isn't an FDA-approved product anymore and isn't prescribed for a covered diagnosis in most cases. The price you pay reflects the compounding pharmacy's cost plus any bundled provider visits and labs.

Is sermorelin cheaper than HGH?

Yes, usually by a wide margin. Compounded sermorelin often runs $150 to $500 a month, while pharmacy-grade HGH (somatropin) for diagnosed adult growth hormone deficiency frequently runs into four figures monthly. But they aren't interchangeable: HGH is the FDA-approved replacement hormone itself, while sermorelin stimulates your own pituitary to release GH, with a more modest effect.

Why isn't there a brand-name sermorelin product anymore?

Sermorelin was sold in the US as Geref, an FDA-approved product, until the manufacturer discontinued it. Discontinuation was a business decision, not a safety withdrawal. Because no branded version remains, every legal sermorelin option today comes from a licensed compounding pharmacy using sermorelin acetate as a bulk substance.

Why is some sermorelin sold online so cheap?

Ultra-cheap sermorelin sold without a prescription is typically a research-chemical product, not a pharmacy-grade one. It skips prescriber evaluation, sterility testing, and quality documentation, all of which cost money in a legitimate pharmacy channel. Investigations into falsified biopharmaceutical injectables in Europe found a real market for substandard product, which is part of why unregulated sourcing carries genuine risk.

Does the price include lab testing?

Not always. Some clinics bundle IGF-1 lab monitoring into a flat monthly fee, others charge for the prescription and vial only and leave labs as an optional add-on. Ask specifically what's included before comparing quotes, since two prices that look different might reflect very different scopes of care.

What's the difference between 503A and 503B compounded sermorelin, and does it affect price?

503A pharmacies compound patient-specific prescriptions, typically in smaller batches. 503B outsourcing facilities compound larger batches under stricter oversight without needing a prescription per batch. 503B products can cost slightly more due to higher compliance overhead, but both are legal compounding routes under the FD&C Act's bulk drug substance rules.

Is sermorelin FDA-approved?

No FDA-approved sermorelin product remains on the market. It was previously approved as Geref and was discontinued by its manufacturer for business reasons, not pulled for safety. Legal sermorelin today is compounded under sections 503A or 503B of the FD&C Act rather than sold as an approved drug.

Can I get sermorelin covered by insurance?

Almost never for adult use. Insurance coverage generally requires an FDA-approved, on-label indication, and sermorelin's approved history (as Geref, for diagnostic and pediatric growth hormone deficiency use) doesn't map onto how it's prescribed off-label to adults today. Budget for cash pay.

How does sermorelin's cost compare to oral GH secretagogues like MK-677?

MK-677 is sold outside pharmacy channels since it isn't FDA-approved for human use, so pricing is inconsistent and not tied to any compounding standard. Sermorelin, even though also unapproved as a finished product now, at least runs through a regulated compounding pathway with sterility and dosing accountability that oral secretagogue sellers typically don't offer.

What should be included in a fair sermorelin price quote?

A fair quote should specify the prescriber visit, any baseline or follow-up labs (typically IGF-1), the compounded medication and dose, injection supplies, and which pharmacy fills the prescription. If a provider can't answer which pharmacy is compounding your sermorelin, treat that as a red flag regardless of price.

Does a higher price mean better quality sermorelin?

Not necessarily, but a price with zero medical oversight attached is a warning sign regardless of how low or high it is. The meaningful quality signals are a real prescriber evaluation, a named licensed compounding pharmacy (503A or 503B), and lab monitoring, not the dollar figure alone.

Why do sermorelin prices vary so much between clinics?

Variation comes from dose differences, whether visits and labs are bundled, and which compounding pharmacy fills the script. A bare vial price from a standalone pharmacy will look cheaper than a full telehealth package that includes prescriber time and lab monitoring, even though the underlying medication cost may be similar.

Sources

1. FDA, Drugs@FDA database: Public database for checking current approval status of drug products, including discontinued ones like the branded sermorelin product Geref.
2. FDA, 21 CFR 216.24, the 503B Bulks List: Section 503B covers outsourcing facilities compounding in larger batches under stricter oversight, without a patient-specific prescription required per batch.
3. FDA, 21 CFR 216.23, the final 503A Bulks List: Section 503A governs compounding pharmacies preparing patient-specific prescriptions using approved bulk drug substances.
4. Cornell Legal Information Institute, 21 U.S.C. 353a: Federal statute governing pharmacy compounding requirements that legal sermorelin providers must operate under.
5. Clinical Interventions in Aging, 2006 (PMID 18046908): Sermorelin is described as a management approach for adult-onset growth hormone insufficiency that works through the body's natural GH feedback loop.
6. Translational Andrology and Urology, 2020 (PMID 32257855): Growth hormone secretagogues are framed as one tool in modern management of body composition in hypogonadal males, acting through the endogenous GH-IGF-1 axis.
7. American Journal of Men's Health, 2017 (PMID 28830317): Growth hormone secretagogue treatment in hypogonadal men was found to raise serum IGF-1 levels in a study.
8. Drug Testing and Analysis, 2016 (PMID 26456392): An investigation into falsified antibiotics and biopharmaceutical injectables in Europe documented a real market for substandard or falsified injectable products.
9. Frontiers in Endocrinology, 2026 (PMID 42395176): Describes a widening gap between clinical evidence for GH-IGF-1 axis peptides and the reality of patient self-administration outside medical supervision.
10. Journal of Sports Medicine and Physical Fitness, 2026 (PMID 41880199): A critical review documents the rise of peptide and peptide-analog drug use in recreational and professional sport and bodybuilding.
11. Analytical and Bioanalytical Chemistry, 2016 (PMID 26879649): Describes a method using immunoaffinity purification and LC-HRMS/MS to qualitatively identify growth hormone-releasing hormones in human plasma.
12. Journal of Chromatography A, 2020 (PMID 32971474): Compares magnetic bead surface functionalities used for immunopurification of growth hormone-releasing hormones prior to LC-HRMS analysis.
13. Journal of Pharmaceutical and Biomedical Analysis, 2022 (PMID 35298973): Describes an antibody-free, ultrafiltration-based nanoLC-HRMS/MS assay able to detect growth hormone-releasing hormones in urine at low picogram-per-milliliter concentrations.
14. Biomedical Chromatography, 2023 (PMID 37688464): Studied enzymatic and serum stability and degradation profiles of GHRP and GHRH-related peptides using in-house reference standards.
15. BioDrugs, 1999 (PMID 18031173): Reviews sermorelin's use in diagnosing and treating idiopathic growth hormone deficiency in children.
16. Annals of Translational Medicine, 2021 (PMID 33842627): Discusses sermorelin as a potentially effective drug for patients with recurrent glioma, a research direction unrelated to body composition use.
17. Frontiers in Surgery, 2026 (PMID 42465868): A case report describes anterior cervical osteophyte-related dysphagia in a long-term growth hormone user, illustrating a physical risk of prolonged GH axis manipulation.
18. FDA, bulk drug substances used in compounding under section 503A: FDA maintains an official list of bulk drug substances, including determinations relevant to sermorelin acetate, permitted for 503A compounding.
19. FDA, bulk drug substances nominated for use in compounding (current list): FDA's nominated bulk drug substances list documents substances under review or accepted for compounding use, relevant to how sermorelin acetate is regulated as a compounding ingredient.